DiscoverMad in America: Science NewsScience News: Antipsychotics and Cancer, Screening for Depression, and Alzheimer's Drug Controversy
Science News: Antipsychotics and Cancer, Screening for Depression, and Alzheimer's Drug Controversy

Science News: Antipsychotics and Cancer, Screening for Depression, and Alzheimer's Drug Controversy

Update: 2021-10-26
Share

Description

This week, Peter Simons covers a study that found prolactin-increasing antipsychotics associated with increased breast cancer risk, an analysis that found no convincing evidence that screening for depression improves outcomes, and the continuing controversy around the FDA's approval of Biogen's failed Alzheimer's drug aducanumab.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Science News: Antipsychotics and Cancer, Screening for Depression, and Alzheimer's Drug Controversy

Science News: Antipsychotics and Cancer, Screening for Depression, and Alzheimer's Drug Controversy